Li, Yingchun et al
"ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models." Molecular Cancer Therapeutics
17.5
(2018):
1039-1050.
Web. 29 Oct. 2020.
